TM
MSGS icon

Thrax Management’s Madison Square Garden MSGS Stock Holding History

Thrax Management’s Portfolio MSGS Stock Details MSGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,064
Closed -$2.1M – 178
2016
Q2 		$2.1M Buy
+17,064
New +$2M 0.32% 67

Other funds holding MSGS

Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Thrax Management's MSGS Position: Q3 2016 in Review

Thrax Management sold out of Madison Square Garden (MSGS) in Q3 2016, closing a stake of 17,064 shares — an estimated $2.1M sold.

Thrax Management first reported a position in MSGS in Q2 2016 and held it in 1 quarter. The position peaked at $2.1M in Q2 2016. 214 funds tracked by Wall St. Rank hold MSGS as of Q3 2016.

  • Thrax Management reported no remaining Madison Square Garden position as of Q3 2016 after selling out during the quarter.
  • Thrax Management sold 17,064 Madison Square Garden shares in Q3 2016, an estimated $2.1M.
  • Thrax Management first reported a position in Madison Square Garden in Q2 2016 and held it in 1 quarter.
  • Thrax Management's Madison Square Garden position peaked at $2.1M in Q2 2016.
  • 214 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2016.

Based on Thrax Management's 13F filing for Q3 2016, filed 14 Nov 2016.